W. Kimryn Rathmell, MD, PhD
Chief of Medicine and Physician-in-Chief
Vanderbilt University Medical Center
“So, what can people do? One is talk to their congressmen and say that funding for kidney cancer research and particularly for rare tumors of the kidney needs to continue.”
Education
Dr. Kimryn Rathmell is a genitourinary oncologist and physician-scientist focused on renal cell carcinoma (RMC). She received her MD and PhD in biophysics at Stanford University, completed internal medicine training at the University of Chicago and University of Pennsylvania, and completed a medical oncology fellowship at the University of Pennsylvania.
Dr. Rathmell has assisted in leading several Cancer Genome Atlas efforts and has a clinical and translational trials program focused on pre-operative therapy and integrated genomics and functional imaging. Dr. Rathmell has also served in leadership roles for the American Society of Clinical Oncology (ASCO), American Society of Clinical Investigators, Kidney Cancer Association, Society of Urologic Oncology, NIH Kidney Cancer Task Force, and other medical organizations. Dr. Rathmell has also authored and co-authored many peer-reviewed articles in medical journals and serves as a mentor for other physician-scientists.
